Sirius Therapeutics Inc. raised nearly $50 million in a series B2 financing round May 9 to support its pipeline of small interfering RNA (siRNA) molecules for cardiovascular disease indications.

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

With our open-source code, datasets, and model weights, global researchers can enhance its accuracy, apply it to new RNA ...

Pipeline development remains a priority, with management cognizant of the high risks associated with neurodevelopmental disorder treatments. Sage Therapeutics demonstrated strong commercial ...

April 15, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq ... event on April 29 th at 8:00 a.m. ET to review key pipeline updates in conjunction with the 2025 American Association ...

demonstrating potent combination of epigenetic regulation and capsid delivery technology in treating prion disease in animal models "We are proud to be showcasing our latest pipeline advances at ...

--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq ... Presentations will highlight the progression of Sangamo’s neurology pipeline, including advances in zinc finger epigenetic regulation ...

demonstrating potent combination of epigenetic regulation and capsid delivery technology in treating prion disease in animal models "We are proud to be showcasing our latest pipeline advances at ASGCT ...

In 2015, an oil pipeline burst off the coast of Santa Barbara County. Over 450,000 gallons of heavy crude spilled into the surrounding environment, spreading out across 136 miles of coastline. Now, a ...

Across the recent three months, 4 analysts have shared their insights on United Therapeutics UTHR ... In addition, it is developing a pipeline of projects that includes new indications and ...

Mosaic Therapeutics a UK-based oncology company has announced ... He added: “The in licensing of these two clinical-stage assets provides a step change in our development pipeline allowing Mosaic to ...

Merck KGaA is nearing a deal to acquire SpringWorks Therapeutics Inc., people familiar with the matter said. An announcement may come as soon as Monday, the people said, asking not to be ...